A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in the ...

Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Professor Martin Kaiser is the Chair of Haematology, group leader of the Myeloma Molecular Therapy group, and an Honorary Consultant Haematologist at The Royal Marsden NHS Foundation Trust. Group: ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...

Image: Leiomyosarcoma. Credit: Wikimedia Commons. A new study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumours have ...

There was a celebration of entrepreneurship at the heart of our ‘Above and Beyond’ staff and student awards ceremony here at the ICR this year – one of the highlights of our calendar. Our innovation ...

Collaboration is essential in science. By sharing knowledge, ideas and skills, we can turn a disease from one that is always fatal into one that is often treatable or even curable. This collaboration ...